# Lumen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lumen

- Industry: Medical Devices & Equipment
- Headquarters: Tel Aviv, Israel
- Website: www.lumen.me
- Total disclosed funding: $62M
- Latest round: Series B (Dec 1, 2022)
- Investors on record: 7

## About

Lumen is an innovative health technology company that specializes in a handheld metabolic coach, utilizing real-time breath analysis to optimize individual metabolic health and wellness.Founded in 2014 in Tel Aviv, Israel, Lumen develops a unique device that measures metabolism through breath analysis. The company was co-founded by a team including Avi Smila, Daniel Mor, Dror Ceder, and others. Lumen has raised a total of USD 62.00 mn across multiple funding rounds, with its most recent funding occurring in August 2023 during a Series B round led by Pitango Venture Capital and including other investors such as Almeda Ventures and Hanwha Corporation.Lumen offers the world’s first handheld metabolic coach that assesses metabolic health through real-time breath analysis. The Lumen device evaluates carbon dioxide levels in breath to determine whether the body is burning fat or carbohydrates. This device is paired with a mobile application that gives personalized insights on nutrition and lifestyle, catering to health-conscious individuals and fitness enthusiasts. The customer base includes over 300,000 users globally, primarily focusing on North America and Europe.Lumen generates revenue through direct-to-consumer sales and subscription services. Customers buy the Lumen device along with subscription plans that deliver personalized coaching and health insights. The model encourages customer retention and engagement, with pricing structures designed to attract a variety of consumers interested in optimizing their metabolic health. The company also partners with health professionals and clinics, creating additional revenue channels through B2B collaborations.In August 2023, Lumen secured additional funding from new investors Global Brain and Kirin Holdings Company, Limited, which will support the company in expanding its business. The future strategy involves launching new products aimed at enhancing user experience and improving metabolic health outcomes. Additionally, Lumen plans to enter new markets, focusing on regions that align with their growth objectives and leveraging recent investment to bolster these initiatives.

## Funding rounds

- Series B, Dec 1, 2022, $62M — Pitango, Resolute Ventures, Disruptive Technologies Venture Capital, RiverPark Advisors, Unorthodox Ventures, Almeda Ventures, Hanwha Corporation

## Investors

- Pitango (https://capitalatlas.ai/funds/pitango) — Series B
- Resolute Ventures (https://capitalatlas.ai/funds/resolute-ventures) — Series B
- Disruptive Technologies Venture Capital (https://capitalatlas.ai/funds/disruptive-technologies-venture-capital) — Series B
- RiverPark Advisors (https://capitalatlas.ai/funds/riverpark-advisors) — Series B
- Unorthodox Ventures (https://capitalatlas.ai/funds/unorthodox-ventures) — Series B
- Almeda Ventures (https://capitalatlas.ai/funds/almeda-ventures) — Series B
- Hanwha Corporation — Series B